Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06243016 · ClinicalTrials.gov registry record · NA
Breaking Sitting with High-intensity Interval Training for Brain Health
A NA study of Aging, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT06243016: Recruiting NA study of Aging, sponsored by University of Illinois at Urbana-Champaign.
NCT06243016 is a NA study of Aging that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 54 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06243016, a NA study of Aging, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT breaks to sitting. It will also address several important but unanswered questions: (1) Does interrupting sitting with short HIIT breaks improve frontoparietal function? (2) Can interrupting sitting with HIIT breaks improve cognitive functions?
Primary Outcome
EEG will be used to measure event-related brain potentials including the P3b-component during an inhibitory control task.
Conditions Studied
Interventions
- BEHAVIORAL High-Intensity Interval Training (HIIT) Breaks to Sitting
- BEHAVIORAL Light-Intensity Interval Training (LIIT) Breaks to Sitting
Study Locations (1)
Illinois
- University of Illinois at Urbana-Champaign - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What NCT06243016 shows while recruiting
NCT06243016 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which High-Intensity Interval Training (HIIT) Breaks to Sitting is the first listed.
NCT06243016 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06243016 about?
NCT06243016 is a clinical study titled "Breaking Sitting with High-intensity Interval Training for Brain Health". This trial will examine whether interrupting 3.5 hours of sitting every 30 min with 6 min high intensity interval training (HIIT) breaks compared to light intensity interval training (LIIT) will improve brain health in cognitively normal older adults. This trial will test the feasibility of HIIT bre...
What is the current status of trial NCT06243016?
This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2024-05-07. Estimated completion is 2025-07-31.
What conditions does trial NCT06243016 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT06243016?
The interventions under investigation include: High-Intensity Interval Training (HIIT) Breaks to Sitting (BEHAVIORAL), Light-Intensity Interval Training (LIIT) Breaks to Sitting (BEHAVIORAL).
Who is sponsoring clinical trial NCT06243016?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06243016 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06243016's enrollment target sits among peer trials
54 151st of 262 higher than 112 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI